Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgrastim + ABVD in HIV-Associated Hodgkin's Disease
NCT00000626Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of filgrastim in Hodgkin lymphoma (HL), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
filgrastim
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00000626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000626.